Bio-Renal Transplantation Marginaldner
Conditions
Interventions
Nutritional guidance and assessments are provided 1 months prior to surgery after the decision to transplant the kidney, and 3 and 6 months after kidney transplantation. to provide nutritional guidanc
Sponsors
Asahikawa Medical University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients who are 80 years of age or younger at the time of obtaining consent (2) Patients who meet the Marginal Donor Criteria of the Japanese Society for Transplantation's Living Donor Guidelines for Kidney Transplantation (3) Patients diagnosed as obese (BMI 32 kg/m2 or less) Hypertension [strictly controlled to 130/80 mmHg with antihypertensive medication and urinary albumin The amount of excretion. Less than 30 mg/gCr and organ damage due to hypertension (myocardial hypertrophy, fundus changes, aortic advanced stone Patients diagnosed with [no ashing, etc.] (5) Outpatients (6) Patients who have given written consent to participate in this study
Exclusion criteria
Exclusion criteria: (1) Patients who are unable to continue to quit smoking (2) Patients who deviated from the Marginaldner criteria prior to kidney transplantation. (3) Other patients who are deemed by the physician in charge to be inappropriate for the subject
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decline in weight and BMI at 3 months post-operatively, fluctuations in blood biochemistry data, blood pressure trends, and antihypertensive medication doses. transition | — |
Secondary
| Measure | Time frame |
|---|---|
| Six months post-operatively, weight and BMI decline, blood biochemistry data variation, blood pressure trends, and antihypertensive medication intake. | — |
Countries
Japan
Contacts
Public Contactyurie kurosaka
Asahikawa Medical University Hospital Nutritional Management Department
Outcome results
None listed